Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice

Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice

Reports remain insufficient on whether and how prostate-specific membrane antigen (PSMA) can influence in vivo osseous metastasis of prostate cancer (PCa). In the present study, the authors induced stable expression of PSMA in mouse PCa cell line RM-1. In vivo osseous metastasis was induced in 37 6-...

Full description

Bibliographic Details
Main Authors:	Liang-Yun Zhao, Xiao-Peng Mao, Kai-Yuan Chao, Sheng-Jie Guo, Shao-Peng Qiu
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2012-08-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Prostate carcinoma Prostate-specific membrane antigen In vitro Osseous metastasis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000800008

Similar Items

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
by: Dan Bee Lee, et al.
Published: (2023-01-01)

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
by: Ernani L. Rhoden, et al.
Published: (2003-04-01)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
by: Kyo Chul Koo, et al.
Published: (2015-03-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Nadir prostate-specific antigen as a prognostic factor of 10-year cancer-specific survival of prostate cancer patients with bone metastases
by: Chi-Feng Hung, et al.
Published: (2022-01-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Metastatic Prostatic Adenocarcinoma in an Inguinal Hernia Sac in a Patient with Undetectable Serum Prostate Specific Antigen Level
by: Shiu-Dong Chung, et al.
Published: (2007-05-01)

PREDICTIVE VALUE OF SERUM PROSTATE SPECIFIC ANTIGEN IN DETECTING BONE METASTASIS IN PROSTATE CANCER
by: Raden Danarto, et al.
Published: (2021-07-01)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
by: Bai X, et al.
Published: (2020-08-01)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
by: Satish Sharma, et al.
Published: (2022-05-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Prostate Specific Membrane Antigen PET/MRI for the Management of Prostate Cancer: Current Status and Future Directions
by: LI Hui, et al.
Published: (2022-03-01)

Oral cavity metastasis: An unusual presentation of carcinoma prostate
by: Dileep Damodaran, et al.
Published: (2008-01-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2024-01-01)

Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report
by: Liming Zhu, et al.
Published: (2013-01-01)

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
by: Youngjun Boo, et al.
Published: (2023-07-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
by: Yasuhide Kitagawa, et al.
Published: (2014-12-01)

Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01)

FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AS PREDICTOR FOR PROSTATE CARCINOMA
by: Sajjad Ahmad, et al.
Published: (2017-08-01)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
by: Michael Tzeng, et al.
Published: (2021-08-01)

FREQUENCY OF PROSTATE CARCINOMA HAVING RAISED SERUM PROSTATE SPECIFIC ANTIGEN LEVEL IN TRANSURETHRAL RESECTION OF PROSTATE
by: Unaiza Jamil, et al.
Published: (2020-02-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed
by: Sofia Santos-Lopes, et al.
Published: (2017-01-01)

DIAGNOSIS OF PROSTATIC NEOPLASM LATER TO ANTIBIOTIC TREATMENT IN PATIENTS WITH PROSTATE-SPECIFIC ANTIGEN BETWEEN 4 AND 10 ng/ml (IN SPANISH)
by: Infantes-Burgos Ronald Javier, et al.
Published: (2014-01-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Jun Seok Kim, et al.
Published: (2015-04-01)

Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia
by: Yasuhide Kitagawa, et al.
Published: (2015-06-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Prostate specific antigen levels following transurethral resection of the prostate
by: Roberto C. Fonseca, et al.
Published: (2008-02-01)

The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?
by: Deepak Dubey
Published: (2009-01-01)

Body mass index in relation to prostate-specific antigen-related parameters
by: Dandan Lin, et al.
Published: (2021-09-01)

Ten‐year outcomes of whole‐pelvic intensity‐modulated radiation therapy for prostate cancer with regional lymph node metastasis
by: Kiyonao Nakamura, et al.
Published: (2023-04-01)